Carboxymethyl chitosan
Based on 1 Customer Validation
Carboxymethyl chitosan is a derivative of chitosan. Carboxymethyl chitosan inhibits Apoptosis and ROS. Carboxymethyl chitosan increases the expression of Bcl-2 and reduces the expression of Bax, cytochrome c and caspase-3. Carboxymethyl chitosan inhibits the migration of various cells. Carboxymethyl chitosan exerts antitumor effects on Lewis tumors and hepatocarcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 90%
- CAS No.: 83512-85-0
-
Stockage:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-B2144A
Chitosan (MW 150000) (≥85% deacetylated) -
HY-135969
Glycol chitosan -
HY-10182
Laduviglusib -
HY-B2144B
Chitosan (MW 30000) (≥85% deacetylated) -
HY-B2144K
Chitosan (≥85% deacetylated, viscosity>90 mPa.s, MW 15000) -
HY-148033
Trimethyl chitosan -
HY-B2144E
Chitosan (≥90% deacetylated, Low viscosity,<200mPa.s) -
HY-B2144F
Chitosan (≥80% deacetylated, Medium viscosity,200-400mPa.s) -
HY-B2144C
Chitosan (≥95% deacetylated,viscosity 100-200 mPa.s) -
HY-B2144J
Chitosan (≥90% deacetylated,viscosity 650-700 mPa.s) -
HY-B2144I
Chitosan (≥90% deacetylated,viscosity 10 mPa.s) -
HY-B2144N
Chitosan (≥98% deacetylated,mushroom)
Voir tous les produits spécifiques à Isoform Caspase
More
Activité biologique
Description
|
Bax |
Bcl-2 |
Caspase-3 |
In Vitro
Carboxymethyl chitosan (100 μg/mL; 4 days) promotes the proliferation of normal skin fibroblasts but inhibits the proliferation of keloid fibroblasts[1].
Carboxymethyl chitosan hydrogels show enhanced cell migration compared with standard chitosan hydrogels[2].
Carboxymethylated chitosan (50-200 μg/mL; 8 h) increases the viability of Schwann cells exposed to H2O2 and decreases LDH release in a concentration-dependent manner[3].
Carboxymethyl chitosan (0.5-2.0 mg/mL; 24-48 h) significantly inhibits the migration of human umbilical vein endothelial cells (HUVECs)[4].
Carboxymethyl chitosan (50-200 μg/mL; 1 h) inhibits IL-1β-induced apoptosis of rabbit chondrocytes in a dose-dependent manner[5].
Carboxymethyl chitosan (4.0-5.0 mg/mL; 48 h) decreases viability of OS-RC-2, NCI-H1650, and HT-29 cells[6].
Carboxymethyl chitosan (1.0-5.0 mg/mL; 12-24 h) can significantly inhibit the two-dimensional migration of BEL-7402 cells in a dose-dependent manner[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Schwann cells
-
Concentration:5, 100, 200 μg/mL
-
Incubation Time:8 h
-
Result:Increased the expression of the anti-apoptotic protein Bcl-2 and decreased the expression of the pro-apoptotic proteins Bax, cytochrome c, and caspase-3.
Reduced cell apoptosis rates by 45.9%, 23.2%, and 9.3% at concentrations of 5 μg/mL, 100 μg/mL, and 200 μg/mL, respectively.
In Vivo
Carboxymethyl chitosan (20-120 mg/kg; i.v.; every other day; for seven times) can significantly inhibit the growth of Lewis tumor tissue, increase the spleen index of tumor-bearing mice, and make the liver and lung cells arrange more orderly, indicating its effectiveness in repressing Lewis tumor growth and metastasis[6].
Carboxymethyl chitosan (1350 mg/kg; i.p.) has no significant effects on the coagulation, anticoagulation, fibrinolysis, or hemorheology parameters of rats[8].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming mice (female, 18-22 g, 6-8 weeks old); Mouse hepatocarcinoma H22-bearing tumor model[4]
-
Dosage:75 mg/kg, 150 mg/kg, 300 mg/kg (dissolved in normal saline)
-
Administration:Intraperitoneal injection, administered on days 1, 3, 5, 7, 9, 11, 13
-
Result:Inhibited the growth of H22 tumor tissue.
Showed inhibition rates of 32.63%, 51.43% and 29.89% at doses of 75 mg/kg, 150 mg/kg and 300 mg/kg, respectively.
Decreased CD34, VEGF and increased TIMP-1.
Increased the thymus index and spleen index of the mice, and enhanced serum IFN-γ and TNF-α levels.
Chemical Information
-
CAS No. 83512-85-0
-
Appearance Solid
-
Color White to light yellow
-
SMILES
[Carboxymethyl chitosan]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvant et solubilité
In Vitro:
H2O : 10 mg/mL (Need ultrasonic)
Pureté et documentation
-
Fiche technique (273 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Chen XG, et al. The effect of carboxymethyl-chitosan on proliferation and collagen secretion of normal and keloid skin fibroblasts. Biomaterials. 2002 Dec;23(23):4609-14. [Content Brief]
[2]. Kruczkowska W, et al. Medical Applications and Cellular Mechanisms of Action of Carboxymethyl Chitosan Hydrogels. Molecules. 2024 Sep 13;29(18):4360. [Content Brief]
[3]. He B, et al. Carboxymethylated chitosan protects Schwann cells against hydrogen peroxide-induced apoptosis by inhibiting oxidative stress and mitochondria dependent pathway. Eur J Pharmacol. 2018 Apr 15;825:48-56. [Content Brief]
[4]. Jiang Z, et al. Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo. Carbohydr Polym. 2015 Sep 20;129:1-8. [Content Brief]
[5]. Chen Q, et al. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis. Eur J Pharmacol. 2006 Jul 10;541(1-2):1-8. [Content Brief]
[6]. Jiang Z, et al. Evaluation on biological compatibility of carboxymethyl chitosan as biomaterials for antitumor drug delivery. J Biomater Appl. 2017 Feb;31(7):985-994. [Content Brief]
[7]. Jiang Z, et al. Preparation and anti-tumor metastasis of carboxymethyl chitosan. Carbohydr Polym. 2015 Jul 10;125:53-60. [Content Brief]
[8]. Yang Z, et al. Acute toxicity of high dosage carboxymethyl chitosan and its effect on the blood parameters in rats. J Mater Sci Mater Med. 2012 Feb;23(2):457-62. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Carboxymethyl chitosan Related Classifications
HY-W250111 Related Classifications
Powered by Bioz